Inflammatory/Immune

Expression vector for Leukocyte-Type 12-Lipoxygenase

This research targets 12-Lox.
Licensing manager: 
Mike Villalobos
Read more

Mouse cDNA for CrK-associated substrate

This research targets Cas.
Licensing manager: 
Jody Hankins
Read more

Mouse Focal Adhesion Kinase cDNA

This research targets FAK.
Licensing manager: 
Jody Hankins
Read more

Phosphorylated Focal Adhesion Kinase antisera

This research targets FAK.
Licensing manager: 
Jody Hankins
Read more

Anti-human myeloid cell nuclear differentiation monoclonal antibody

The antibody is a rat IgG1 monoclonal, clone 3C1.
Licensing manager: 
Jody Hankins
Read more

Anti-Armadillo repeat gene deleted in velo-cardiofacial syndrome monoclonal antibody

This research targets ARVCF.
Licensing manager: 
Karen Rufus
Read more

Focal adhesion kinase antisera

This research targets Focal Adhesion Kinase (FAK).
Licensing manager: 
Jody Hankins
Read more

Floxed Prostaglandin D2 receptor alleles

This research targets DP1
Licensing manager: 
Karen Rufus
Read more

Alpha Calcitonin Gene-Related Peptide (CGRP) Null Mice

This research targets CGRP.
Licensing manager: 
Jody Hankins
Read more

Luciferase-expressing Embryonic Stem Cell Line for Monitoring wnt or BMP Promotor Activity

The mouse embryonic stem cell line, CGR8, has been genetically modified to express luciferase under the control of either the wnt or the BMP promoter system. This technology allows rapid visualization or genetic modification of wnt and BMP pathways in development.

Summary

The mouse embryonic stem cell line, CGR8, has been genetically modified to express luciferase under the control of either the wnt or the BMP promoter system.  This technology allows rapid visualization or genetic modification of wnt and BMP pathways in development. 

Licensing manager: 
Mike Villalobos
Read more

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter